These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1232561)

  • 1. Growth hormone secretion in chronic schizophrenia.
    Brambilla F; Guerrini A; Rovere C; Guastalla A; Riggi F; Recchia M
    Neuropsychobiology; 1975; 1(5):267-76. PubMed ID: 1232561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine effects of haloperidol therapy in chronic schizophrenia.
    Brambilla F; Guerrini A; Guastalla A; Rovere C; Riggi F
    Psychopharmacologia; 1975 Oct; 44(1):17-22. PubMed ID: 172929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose-insulin metabolism in chronic schizophrenia.
    Brambilla F; Guastalla A; Guerrini A; Riggi F; Rovere C; Zanoboni A; Zanoboni-Muciaccia W
    Dis Nerv Syst; 1976 Feb; 37(2):98-103. PubMed ID: 1245144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholaminergic drugs in chronic schizophrenia.
    Brambilla F; Scarone S; Ponzano M; Maffei C; Nobile P; Rovere C; Guastalla A
    Neuropsychobiology; 1979; 5(4):185-200. PubMed ID: 375121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulpiride versus haloperidol in schizophrenia: a double-blind comparative trial.
    Cassano GB; Castrogiovanni P; Conti L; Bonollo L
    Curr Ther Res Clin Exp; 1975 Feb; 17(2):189-201. PubMed ID: 234359
    [No Abstract]   [Full Text] [Related]  

  • 6. Psychoendocrine investigation in schizophrenia: relationship between pituitary-gonadal function and behavior.
    Brambilla F; Guerrini A; Riggi F; Ricciardi F
    Dis Nerv Syst; 1974 Aug; 35(8):362-7. PubMed ID: 17894073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine function in schizophrenia.
    Brambilla F
    Acta Psychiatr Belg; 1980; 80(4):421-35. PubMed ID: 6792866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment with bromperidol in schizophrenic patients].
    Ellerman LA
    Acta Psiquiatr Psicol Am Lat; 1989; 35(1-2):23-30. PubMed ID: 2634329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amoxapine as an antipsychotic: comparative study versus haloperidol.
    Chaudhry IB; Husain N; Khan S; Badshah S; Deakin B; Kapur S
    J Clin Psychopharmacol; 2007 Dec; 27(6):575-81. PubMed ID: 18004123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Double-blind clinical study of HF 1854 (LX 100-129, clozapine or leponex) as compared with haloperidol].
    Ciurezu T; Ionescu R; Nica Udangiu S; NiĊ£urad D; Oproiu L; Tudorache D; Popovici I; Curelaru S
    Neurol Psychiatr (Bucur); 1976; 14(1):29-34. PubMed ID: 788132
    [No Abstract]   [Full Text] [Related]  

  • 11. Secretion pattern of endogenous opioids in chronic schizophrenia.
    Brambilla F; Facchinetti F; Petraglia F; Vanzulli L; Genazzani AR
    Am J Psychiatry; 1984 Oct; 141(10):1183-9. PubMed ID: 6091463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computerized EEG: predictor of outcome in schizophrenia.
    Itil TM; Marasa J; Saletu B; Davis S; Mucciardi AN
    J Nerv Ment Dis; 1975 Mar; 160(3):118-203. PubMed ID: 1090708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relations between therapeutic and hormonal response to neuroleptics of patients with paranoid schizophrenia. III. Secretion of growth hormone (GH), adrenocorticotropic hormone (ACTH), cortisol (CORT) and insulin (INS)].
    Horodnicki JM; Pobocha J; Czekalski S; Wdowiak J; Szakowski A
    Psychiatr Pol; 1988; 22(4):290-5. PubMed ID: 2907811
    [No Abstract]   [Full Text] [Related]  

  • 14. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
    Zimbroff DL; Kane JM; Tamminga CA; Daniel DG; Mack RJ; Wozniak PJ; Sebree TB; Wallin BA; Kashkin KB
    Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Schizophrenia and histocompatibility antigens].
    Julien RA; Mercier P; Chouraqui P; Sutter JM
    Encephale; 1978; 4(2):99-113. PubMed ID: 688973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do patients with paranoid and disorganized schizophrenia respond differently to antipsychotic drugs?
    Corves C; Engel RR; Davis J; Leucht S
    Acta Psychiatr Scand; 2014 Jul; 130(1):40-5. PubMed ID: 24299424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trace elements in the hair of schizophrenics.
    Tada K; Nogami Y; Nagashima M; Nagase T; Ishiwata H; Motegi Y; Ikeda M
    Biol Psychiatry; 1986 Mar; 21(3):325-8. PubMed ID: 3947715
    [No Abstract]   [Full Text] [Related]  

  • 18. Haloperidol plasma levels and clinical response in paranoid schizophrenics.
    Linkowski P; Hubain P; von Frenckell R; Mendlewicz J
    Eur Arch Psychiatry Neurol Sci; 1984; 234(4):231-6. PubMed ID: 6526061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance.
    Singh MM
    Dis Nerv Syst; 1976 Apr; 37(4):191-6. PubMed ID: 767080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of psychotic symptom clusters in schizophrenia to neuroleptic treatment and growth hormone response to apomorphine.
    Zemlan FP; Hirschowitz J; Sautter F; Garver DL
    Psychiatry Res; 1986 Jul; 18(3):239-55. PubMed ID: 2875478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.